Diversity MD
In 2015, the U.S. Food and Drug Administration launched a five-year action plan, aiming to improve diversity in clinical trials for newly approved drugs. According to HealthDay, Angela K. Green, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues analyzed Snapshots data to examine whether …
Read More »Black Patients Still Underrepresented In Clinical Trials Despite FDA Action Plan
